Trial · NCT01767909
Adverse events68
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 68
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | BLOOD AND LYMPHATIC SYSTEM DISORDERS | Blood and lymphatic system disorders | Insulin (Humulin® R U-100) | 4 | 121 | 4 |
| other | BLOOD AND LYMPHATIC SYSTEM DISORDERS | Blood and lymphatic system disorders | Placebo | 2 | 119 | 2 |
| other | CARDIAC DISORDERS | Cardiac disorders | Insulin (Humulin® R U-100) | 8 | 121 | 9 |
| other | CARDIAC DISORDERS | Cardiac disorders | Placebo | 6 | 119 | 8 |
| other | DEMENTIA AND AMNESTIC CONDITIONS | Nervous system disorders | Insulin (Humulin® R U-100) | 0 | 121 | 0 |
| other | DEMENTIA AND AMNESTIC CONDITIONS | Nervous system disorders | Placebo | 1 | 119 | 1 |
| other | ENDOCRINE DISORDERS | Endocrine disorders | Insulin (Humulin® R U-100) | 1 | 121 | 1 |
| other | ENDOCRINE DISORDERS | Endocrine disorders | Placebo | 0 | 119 | 0 |
| other | EYE DISORDERS | Eye disorders | Insulin (Humulin® R U-100) | 5 | 121 | 5 |
| other | EYE DISORDERS | Eye disorders | Placebo | 2 | 119 | 2 |
| other | GASTROINTESTINAL DISORDERS | Gastrointestinal disorders | Insulin (Humulin® R U-100) | 21 | 121 | 26 |
| other | GASTROINTESTINAL DISORDERS | Gastrointestinal disorders | Placebo | 13 | 119 | 17 |
| other | GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS | General disorders | Insulin (Humulin® R U-100) | 11 | 121 | 11 |
| other | GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS | General disorders | Placebo | 7 | 119 | 8 |
| other | HEPATOBILIARY DISORDERS | Hepatobiliary disorders | Insulin (Humulin® R U-100) | 1 | 121 | 1 |
| other | HEPATOBILIARY DISORDERS | Hepatobiliary disorders | Placebo | 0 | 119 | 0 |
| other | IMMUNE SYSTEM DISORDERS | Immune system disorders | Insulin (Humulin® R U-100) | 2 | 121 | 2 |
| other | IMMUNE SYSTEM DISORDERS | Immune system disorders | Placebo | 1 | 119 | 1 |
| other | INFECTIONS AND INFESTATIONS | Infections and infestations | Insulin (Humulin® R U-100) | 32 | 121 | 36 |
| other | INFECTIONS AND INFESTATIONS | Infections and infestations | Placebo | 27 | 119 | 32 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01767909/events